Spots Global Cancer Trial Database for female breast cancer
Every month we try and update this database with for female breast cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms | NCT06123286 | Breast Cancer Aromatase Inhib... Joint Pain | Tart Cherry Omega 3 FA (Fis... | 18 Years - | Cedars-Sinai Medical Center | |
| Dose Dense TC + Pegfilgrastim Support for Breast Cancer | NCT01671319 | Female Breast C... | docetaxel + cyc... | 18 Years - | University of Wisconsin, Madison | |
| Exercise, Gut Microbiome, and Breast Cancer: Increasing Reach to Underserved Populations | NCT05000502 | Female Breast C... | Home-based exer... | 18 Years - 70 Years | University of Alabama at Birmingham | |
| This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer. | NCT05439499 | Advanced Breast... Female Breast C... | FCN-437c, Letro... Placebo, Letroz... | 18 Years - | Ahon Pharmaceutical Co., Ltd. | |
| Yoga on QOL Physiological Distress&Fatigue, on Patients Affected by Breast Cancer in Adjuvant Radiotherapy | NCT04775290 | Female Breast C... Fatigue Quality of Life Physiological S... Radiotherapy; C... | Yoga lessons | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer. | NCT05438810 | Advanced Breast... Female Breast C... | FCN-437c,Fulves... Placebo,Fulvest... | 18 Years - | Ahon Pharmaceutical Co., Ltd. | |
| Female Sexual Dysfunction in Breast Cancer Patients | NCT03153631 | Female Breast C... | 18 Years - 40 Years | Assiut University | ||
| Estrogen for Triple Negative Breast Cancer | NCT01083641 | Female Breast C... | Estradiol | 18 Years - | University of Wisconsin, Madison | |
| Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients | NCT05755581 | Female Breast C... | Hormonal Antine... Chemotherapy dr... | 18 Years - | Sohag University | |
| Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer | NCT02089854 | Female Breast C... | Toremifene; Ana... | 18 Years - 80 Years | Peking Union Medical College Hospital | |
| Medical Radiometer - RTM - 01 - RES and Its Use in Detecting Hotspots in Female Breast | NCT02286583 | Breast Cancer | Microwave Therm... | - | Labdom Suisse | |
| A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer | NCT06144164 | Lymphedema Lymphedema Arm Lymphedema of U... Breast Cancer Breast Carcinom... Female Breast C... | Immediate Lymph... Volumetric arm ... Lymphatic massa... Range of motion... Compression gar... | 18 Years - 75 Years | Memorial Sloan Kettering Cancer Center | |
| Conformal High Dose Intensity Modulated Radiation Therapy for Disease to Thoracic and Lumbar Spine | NCT01654068 | Vertebral Metas... | Conformal High ... | 18 Years - | University of Kentucky | |
| Pulsed Electromagnetic Fields for Analgesia Post Mastectomy | NCT06331793 | Female Breast C... Post Operative ... | Active AlgoCare Non-active Algo... | 18 Years - | European Institute of Oncology | |
| This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer. | NCT05439499 | Advanced Breast... Female Breast C... | FCN-437c, Letro... Placebo, Letroz... | 18 Years - | Ahon Pharmaceutical Co., Ltd. | |
| Side Effect Prevention Training (SEPT) for Nocebo Effects in Breast Cancer Patients | NCT01741883 | Female Breast C... | Side effect pre... Attention Contr... | 18 Years - 80 Years | Philipps University Marburg Medical Center | |
| Breast Cancer in Young Women: Is it Different? | NCT01320488 | Female Breast C... | 40 Years - | National Guard Health Affairs | ||
| Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serum Biomarkers and on PBMCs in Breast Cancer Surgery | NCT03005860 | Female Breast C... | 2,6-Diisopropyl... Fluoromethyl he... Fentanyl Citrat... Atracurium Besy... | 18 Years - | Tata Memorial Centre | |
| Ultra-hypofractionated Radiotherapy in Breast Cancer Patients | NCT05586256 | Female Breast C... | ultra-hypofract... | 18 Years - 99 Years | University Of Perugia | |
| PrefeRences And ChemoTherapy In Breast Cancer patiEnts | NCT06332976 | Female Breast C... | Completion of q... | 18 Years - | European Institute of Oncology | |
| Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients | NCT05755581 | Female Breast C... | Hormonal Antine... Chemotherapy dr... | 18 Years - | Sohag University | |
| A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With BRCA Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer | NCT05258747 | Ovarian Cancer Breast Cancer | Olaparib tablet... Lynparza® (olap... | 18 Years - 85 Years | Sandoz | |
| An Intervention for Female Breast CANcer: Acceptance and Commitment Therapy (I-CAN-ACT) for Depression and Physical Pain | NCT05374161 | Female Breast C... Depression Pain | Acceptance and ... Waitlist Contro... | 18 Years - 99 Years | University of Cyprus | |
| Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer | NCT02089854 | Female Breast C... | Toremifene; Ana... | 18 Years - 80 Years | Peking Union Medical College Hospital | |
| Side Effect Prevention Training (SEPT) for Nocebo Effects in Breast Cancer Patients | NCT01741883 | Female Breast C... | Side effect pre... Attention Contr... | 18 Years - 80 Years | Philipps University Marburg Medical Center | |
| Place of Comprehensive Geriatric Assessment in Patients ≥ 75 Years Care, With Breast Cancer, After Screening With FOG (Oncology Geriatric Filter) | NCT03059875 | Surgery 75 Years Old an... Female Breast C... | Medical consult... | 75 Years - | Poitiers University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
